Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Courvalin

Showing results (271-280 of 295) with videos related to

Pageof 30
Sort By:
Biochemistry|October 29, 1991
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanAT D Bugg, G D Wright, S Dutka-Malen, et al.
Molecular Microbiology|April 21, 1999
Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174C A Arias, M Martín-Martinez, T L Blundell, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1987
Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamaseD Sirot, J Sirot, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre studyC J Soussy, M Cluzel, M C Ploy, et al.
Pathologie-Biologie|October 18, 2008
[Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast]N Guessennd, S Bremont, V Gbonon, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitroT D Gootz, R Zaniewski, S Haskell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1992
Resistance of enterococci to aminoglycosides and glycopeptidesR Leclercq, S Dutka-Malen, A Brisson-Noël, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in FranceA Morvan, C Moubareck, A Leclercq, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2009
New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strainsF Depardieu, M-L Foucault, J Bell, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS)S Bronzwaer, U Buchholz, P Courvalin, et al.
Pageof 30

Showing results (271-280 of 295) with videos related to

Sort By:
Pageof 30
Biochemistry|October 29, 1991
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanAT D Bugg, G D Wright, S Dutka-Malen, et al.
Molecular Microbiology|April 21, 1999
Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174C A Arias, M Martín-Martinez, T L Blundell, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1987
Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamaseD Sirot, J Sirot, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre studyC J Soussy, M Cluzel, M C Ploy, et al.
Pathologie-Biologie|October 18, 2008
[Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast]N Guessennd, S Bremont, V Gbonon, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitroT D Gootz, R Zaniewski, S Haskell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1992
Resistance of enterococci to aminoglycosides and glycopeptidesR Leclercq, S Dutka-Malen, A Brisson-Noël, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in FranceA Morvan, C Moubareck, A Leclercq, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2009
New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strainsF Depardieu, M-L Foucault, J Bell, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS)S Bronzwaer, U Buchholz, P Courvalin, et al.
Pageof 30